CryoCath Technologies
Arctic Front

With 400,000 new cases every year, Atrial Fibrillation is the most prevalent cardiac arrhythmia affecting over four million patients in the world. Farm developed the industrial design and human factors for the proximal portion of CryoCath’s minimally invasive Arctic Front balloon catheter, used to reduce or completely eliminate AF. The Arctic Front balloon catheter creates lesions in the antrum or at the ostium of the targeted pulmonary vein for the treatment of paroxysmal atrial fibrillation. Comfort, size, flexibility and ergonomics were imperative in the development of this product. Farm also developed the user feature to assist with balloon retraction.

Additional Information:

www.cryocath.com

CryoCath Technologies
FrostByte

Farm developed the industrial design and human factors for the FrostByte/SurgiFrost system, the first two-in-one convertible device that incorporates a clamp and a surgical probe used by interventional cardiologist to ablate cardiac arrhythmias using cryogenic technology. The probe locks inside the upper jaw of the clamp, providing simplicity and ease of use for the surgeon. A narrow overall configuration was incorporated to ensure that it stays clear of the surgeon’s line of vision. An integrated latch was designed to allow the clamp to remain locked, which in turn reduces hand fatigue and guarantees a specific and consistent amount of force to the cardiac tissue.

Additional Information:

www.cryocath.com

CryoCath Technologies
Cryo-ablation Catheter Research

Farm conducted a comprehensive investigation to assist CryoCath in understanding the unique requirements of North American and European Interventional Cardiologists and Electrophysiologists for catheter-based surgical procedures. Our research team established a two-phase approach for this investigation. The first phase included on-site field visits, procedure observation and competitive benchmarking in order to determine specific features based on user needs and workflow. This information was used to develop a number of concepts that were tested for ergonomic preference and market acceptance in the second phase. This research identified significant differences between North American and European physician preferences, ultimately influencing CryoCath's product marketing and design requirements for future products.